INSTALLED BUILDING PRODUCTS, INC.
IBP
$224.21
-1.94%
Installed Building Products, Inc. is a leading installer of insulation and complementary building products for the residential new construction market in the United States. The company differentiates itself through its nationwide scale and diversified product offerings, including waterproofing, fire-stopping, garage doors, and window blinds, positioning it as a key partner for homebuilders. Investor attention is currently focused on the company's exposure to the cyclical housing market, with recent revenue declines and a sharp stock price drop from 52-week highs raising questions about near-term demand. The stock has also been highlighted as a potentially safer alternative to TopBuild following QXO's acquisition bid, adding a layer of strategic interest.…
IBP
INSTALLED BUILDING PRODUCTS, INC.
$224.21
Related headlines
Investment Opinion: Should I buy IBP Today?
Rating: Hold. IBP is a high-quality operator in a cyclical industry, but near-term headwinds from declining revenue and margin compression, combined with a premium valuation, limit upside. The analyst consensus is hold with an average target of $233.27, implying only 2% upside.
Supporting Evidence: Trailing P/E of 26.58x is above the industry average of ~18x, but forward P/E of 20.43x suggests expected earnings growth. Revenue declined 3.55% YoY, but the company maintains a strong ROE of 37.39%. Free cash flow improved to $85.7M in Q1 2026, and the dividend yield is 1.26%. The analyst high target of $286 offers 25% upside, but the low target of $200 implies 12.5% downside.
Risks & Conditions: The hold rating would upgrade to buy if housing starts rebound and revenue growth turns positive, or if the P/E compresses below 20x. It would downgrade to sell if revenue declines accelerate beyond 5% or margins continue to shrink. Overall, IBP is fairly valued relative to its history but overvalued compared to peers, given the cyclical risks.
Sign up to view all
IBP 12-Month Price Forecast
IBP is a neutral outlook given the conflicting signals: strong profitability (ROE 37.39%) and improving free cash flow are offset by revenue decline and premium valuation. The base case of a range-bound stock with modest downside is most likely. A bullish stance would require evidence of a housing recovery, while a bearish stance would be triggered by further deterioration in fundamentals. The high beta adds risk, making the stock suitable only for investors with a high risk tolerance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on INSTALLED BUILDING PRODUCTS, INC.'s 12-month outlook, with a consensus price target around $233.27 and implied upside of +4.0% versus the current price.
Average Target
$233.27
0 analysts
Implied Upside
+4.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$200 - $286
Analyst target range
The stock is covered by 11 analysts, with a consensus recommendation of 'hold' (mean rating 2.85 on a 5-point scale). The average target price is $233.27, implying a modest 2.0% upside from the current price of $228.65. The distribution shows 1 buy (Goldman Sachs), 6 holds, and 1 underweight (JP Morgan), reflecting a cautious stance. The target range spans from a low of $200.00 to a high of $286.00. The high target of $286.00 assumes a recovery in housing demand and margin expansion, representing 25% upside. The low target of $200.00 implies a 12.5% downside, likely pricing in continued revenue declines and margin compression. Recent rating actions show no major upgrades or downgrades, with firms like DA Davidson and Truist maintaining neutral/hold ratings. The relatively tight spread between the low and high targets (86 points) suggests moderate uncertainty, but the consensus hold rating indicates analysts see limited near-term catalysts. The implied upside of only 2% to the average target reinforces the neutral sentiment.
Bulls vs Bears: IBP Investment Factors
IBP presents a mixed picture: strong historical profitability (ROE 37.39%) and improving free cash flow are countered by declining revenue (-3.55% YoY), margin compression, and a high valuation (P/E 26.58x vs. industry 18x). The stock is in a clear downtrend, down 26% over 6 months, and analyst consensus is a hold with only 2% upside to the average target. The bull case hinges on a housing recovery and the stock being a safer play amid the QXO-TopBuild deal, while the bear case focuses on continued revenue declines and multiple compression. The key tension is whether the housing market will rebound enough to reverse the revenue decline and justify the premium valuation.
Bullish
- Strong ROE and Profitability: IBP's return on equity (ROE) is 37.39%, significantly above the industry average, indicating efficient capital use and strong historical profitability. This suggests the company has a competitive advantage in its niche.
- Potential Safe Haven from QXO Deal: Recent news highlights IBP as a potentially safer alternative to TopBuild following QXO's acquisition bid, which could attract investors seeking less integration risk. This strategic interest may support the stock price.
- Improving Free Cash Flow: Free cash flow improved to $85.7 million in Q1 2026 from $71.9 million a year earlier, and TTM free cash flow stands at $63.1 million. This provides financial flexibility for debt reduction or shareholder returns.
- Analyst Upside to High Target: The analyst high target of $286.00 implies 25% upside from the current price of $228.65, suggesting that if housing demand recovers, the stock could see significant gains. This provides a potential catalyst for bullish investors.
Bearish
- Revenue Decline and Margin Compression: Revenue fell 3.55% YoY in Q1 2026 to $660.5 million, and gross margin contracted from 32.67% to 30.55%. Operating margin also dropped from 10.19% to 8.87%, indicating worsening profitability.
- High Valuation Relative to Peers: Trailing P/E of 26.58x is a 48% premium to the industry median of ~18x, leaving little room for error. If earnings disappoint, the multiple could contract significantly.
- Downtrend and High Beta: The stock is down 26.17% over 6 months and 23.18% over 3 months, with a beta of 1.705, amplifying market downturns. The price is well below the 52-week midpoint, indicating bearish momentum.
- Elevated Debt-to-Equity Ratio: Debt-to-equity of 1.48 is high, and with earnings declining, interest coverage could become a concern. Net income fell 23.3% YoY in Q1 2026, increasing financial risk.
IBP Technical Analysis
IBP is in a clear downtrend from its 52-week high of $349.00, with the current price of $228.65 representing only 65.5% of the 52-week range. The 1-year price change of +19.23% masks a significant deterioration, as the stock has fallen 26.17% over the past 6 months and 23.18% over the past 3 months. The price sits well below the midpoint of the range, suggesting bearish sentiment and potential further downside risk. Short-term momentum shows a conflicting signal: the 1-month change is +8.21%, indicating a recent bounce, but this follows a brutal 3-month decline of -23.18%. This divergence could represent a dead-cat bounce or the start of a mean-reversion rally, but the longer-term downtrend remains intact. The stock's beta of 1.705 implies it is 70.5% more volatile than the S&P 500, amplifying both upside and downside moves. The 52-week low of $182.88 provides key support; a break below that level would signal a continuation of the bear trend. Conversely, resistance at the 52-week high of $349.00 is far above, and a breakout above the recent 3-month high near $235 would be needed to suggest a trend reversal.
Beta
1.71
1.71x market volatility
Max Drawdown
-43.2%
Largest decline past year
52-Week Range
$185-$349
Price range past year
Annual Return
+21.8%
Cumulative gain past year
| Period | IBP Return | S&P 500 |
|---|---|---|
| 1m | +2.7% | -0.6% |
| 3m | -28.7% | +5.4% |
| 6m | -26.8% | +8.3% |
| 1y | +21.8% | +18.3% |
| ytd | -16.2% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBP Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q1 2026) reporting $660.5 million, down 3.55% year-over-year from $684.8 million in Q1 2025. This marks a deceleration from the prior year's growth trajectory, as Q2 2025 revenue was $760.3 million and Q3 2025 was $778.2 million. The decline is broad-based, with the core insulation segment (the largest at $376.5 million) likely feeling pressure from a slowdown in housing starts. The company remains profitable, with net income of $34.8 million in Q1 2026, though this is down from $45.4 million in Q1 2025. Gross margin compressed to 30.55% in Q1 2026 from 32.67% a year earlier, reflecting cost pressures or pricing headwinds. Operating margin also fell to 8.87% from 10.19%, indicating that profitability is being squeezed. The company's balance sheet shows a debt-to-equity ratio of 1.48, which is elevated but manageable given the current ratio of 3.03 and cash of $474.3 million. Free cash flow was $85.7 million in Q1 2026, improving from $71.9 million in Q1 2025, and the TTM free cash flow of $63.1 million provides some cushion. Return on equity (ROE) stands at 37.39%, indicating strong historical profitability, but the high leverage (debt-to-equity of 1.48) introduces financial risk if earnings continue to decline.
Quarterly Revenue
$660500000.0B
2026-03
Revenue YoY Growth
-3.5%
YoY Comparison
Gross Margin
30.6%
Latest Quarter
Free Cash Flow
$63100000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBP Overvalued?
Since net income is positive, the trailing P/E ratio of 26.58x is the primary valuation metric. The forward P/E of 20.43x implies that earnings are expected to grow, narrowing the multiple. The gap between trailing and forward P/E suggests the market anticipates a recovery in earnings, which is consistent with analyst estimates for EPS of $13.28 in the coming year. Compared to the industry average (Residential Construction), IBP trades at a premium: the trailing P/E of 26.58x is above the sector median of roughly 18x, representing a ~48% premium. This premium may be justified by IBP's strong ROE of 37.39% and dominant market position, but it also leaves the stock vulnerable if growth disappoints. Historically, IBP's trailing P/E has ranged from 8.8x (Q4 2022) to 51.0x (Q1 2026). The current 26.58x is near the middle of this range, suggesting the stock is not at extreme valuation levels. However, the recent spike to 51x in Q1 2026 was due to depressed earnings, and the current multiple reflects a normalization. The price-to-book ratio of 9.83x is also elevated, indicating the market is pricing in significant intangible value and future growth.
PE
26.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IBP's revenue declined 3.55% YoY in Q1 2026, and net income fell 23.3% from $45.4M to $34.8M. Gross margin compressed from 32.67% to 30.55%, and operating margin from 10.19% to 8.87%, indicating cost pressures. The debt-to-equity ratio of 1.48 is elevated, and while the current ratio of 3.03 provides liquidity, the high leverage amplifies earnings volatility. Free cash flow improved to $85.7M, but TTM free cash flow of $63.1M is modest relative to debt obligations.
Market & Competitive Risks: IBP trades at a trailing P/E of 26.58x, a 48% premium to the industry median of ~18x, making it vulnerable to valuation compression if growth disappoints. The stock's beta of 1.705 implies 70.5% more volatility than the market, amplifying downside in a downturn. The residential construction sector is cyclical and sensitive to interest rates; recent housing starts data shows weakness. The QXO-TopBuild deal could shift competitive dynamics, but IBP may benefit as a safer alternative.
Worst-Case Scenario: If housing demand continues to weaken, revenue could decline further, margins could compress, and the stock could fall to its 52-week low of $182.88, representing a 20% downside from the current price of $228.65. In a severe recession, the stock could test the historical max drawdown of -43.16%, implying a price near $130, a 43% loss from current levels.
FAQ
The key risks are: 1) Financial risk from declining revenue (-3.55% YoY) and margin compression (gross margin down 212 bps), which could lead to earnings misses. 2) Valuation risk from a high P/E (26.58x) that could contract if growth slows. 3) Macro risk from a housing downturn, given the stock's high beta (1.705) and cyclical exposure. 4) Company-specific risk from high debt-to-equity (1.48), which increases financial leverage. The most severe risk is a prolonged housing recession that could drive the stock to its 52-week low of $182.88, a 20% downside.
The 12-month forecast is neutral. The base case (50% probability) sees the stock trading between $210 and $240, near the analyst average target of $233.27. The bull case (25% probability) targets $250-$286, driven by a housing recovery. The bear case (25% probability) targets $183-$210, with the stock falling to the 52-week low of $182.88. The most likely scenario is a range-bound stock with limited upside, as reflected in the consensus hold rating.
IBP is overvalued relative to its industry peers. The trailing P/E of 26.58x is a 48% premium to the residential construction industry median of ~18x. However, the forward P/E of 20.43x suggests expected earnings growth, and the PEG ratio of 3.99x indicates the market is pricing in above-average growth. Historically, the P/E has ranged from 8.8x to 51x, so the current level is near the middle. The market is paying a premium for IBP's strong ROE and market position, but this leaves the stock vulnerable if growth disappoints.
IBP is a hold at current levels. The stock offers a 2% upside to the average analyst target of $233.27, but with a 12.5% downside to the low target of $200. The company has strong profitability (ROE 37.39%) and improving free cash flow, but revenue is declining (-3.55% YoY) and margins are compressing. The high beta of 1.705 adds risk. It could be a good buy for long-term investors if housing recovers, but near-term headwinds suggest waiting for a better entry point or confirmation of a turnaround.
IBP is more suitable for long-term investment due to its cyclical nature and high volatility (beta 1.705). Short-term trading is risky given the downtrend and negative momentum (down 23% over 3 months). Long-term investors can benefit from the company's strong ROE (37.39%) and potential for recovery when housing rebounds. A minimum holding period of 3-5 years is recommended to ride out the cycle. The dividend yield of 1.26% provides some income, but the payout ratio of 33% suggests room for growth.